Advanced Search

National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 5) (PB 69 of 2015)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 69 of 2015
National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 5)
National Health Act 1953
I, KYLIE JONASSON, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 27 July 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KYLIE JONASSON
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 5).
            (2)        This Instrument may also be cited as PB 69 of 2015.
2          Commencement
            This Instrument commences on 1 August 2015.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1] Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)
omit from the column headed “Claimed Price”:          4.94        substitute:             8.29
[2] Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)
omit from the column headed “Claimed Price”:          7.64        substitute:             11.25
[3] Schedule 1, entry for Amoxycillin in the form Capsule 250 mg (as trihydrate)
omit from the column headed “Claimed Price”:          2.96        substitute:             3.44
[4] Schedule 1, entry for Amoxycillin in the form Capsule 500 mg (as trihydrate)
omit from the column headed “Claimed Price”:          3.71        substitute:             4.28
[5] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL
omit from the column headed “Claimed Price”:          2.88        substitute:             3.35
[6] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL
omit from the column headed “Claimed Price”:          3.20        substitute:             3.68
[7] Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
omit from the column headed “Claimed Price”:          3.44        substitute:             3.90
[8] Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL
omit from the column headed “Claimed Price”:          4.87        substitute:             5.51
[9] Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
omit from the column headed “Claimed Price”:          5.05        substitute:             5.75
[10]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
omit from the column headed “Claimed Price”:          6.72        substitute:             7.63
[11]         Schedule 1, entry for Atenolol
omit from the column headed “Claimed Price”:          2.64        substitute:             3.33
[12]         Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg
omit from the column headed “Claimed Price”:          16.07     substitute:             16.81
[13]         Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg
omit from the column headed “Claimed Price”:          19.57     substitute:             20.31
[14]         Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg
omit from the column headed “Claimed Price”:          24.00     substitute:             24.69
[15]         Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg
omit from the column headed “Claimed Price”:          2.39        substitute:             2.98
[16]         Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg
omit from the column headed “Claimed Price”:          4.58        substitute:             5.16
[17]         Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg
omit from the column headed “Claimed Price”:          11.16     substitute:             11.74
[18]         Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg
omit from the column headed “Claimed Price”:          13.22     substitute:             13.80
[19]         Schedule 1, entry for Clindamycin
omit from the column headed “Claimed Price”:          10.44     substitute:             16.66
[20]         Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity: 20]
omit from the column headed “Claimed Price”:          18.67     substitute:             19.85
[21]         Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity: 50]
omit from the column headed “Claimed Price”:          43.32     substitute:             43.87
[22]         Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 100 mg
omit from the column headed “Claimed Price”:          66.92     substitute:             67.92
[23]         Schedule 1, entry for Desferrioxamine
omit:
 
Powder for injection containing desferrioxamine mesylate 2 g
Injection
Desferal 2 g
1
28.74
29.03
[24]         Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg
omit from the column headed “Claimed Price”:          2.14        substitute:             2.70
[25]         Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg
omit from the column headed “Claimed Price”:          3.32        substitute:             4.45
[26]         Schedule 1, entry for Doxepin in the form Capsule 10 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          5.14        substitute:             8.28
[27]         Schedule 1, entry for Doxepin in the form Capsule 25 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          5.14        substitute:             8.27
[28]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Doryx; Pricing Quantity/Pack Quantity: 7]
omit from the column headed “Claimed Price”:          2.50        substitute:             3.31
[29]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Mayne Pharma Doxycycline; Pricing Quantity/Pack Quantity: 7]
omit from the column headed “Claimed Price”:          1.56        substitute:             2.09
[30]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Doryx; Pricing Quantity/Pack Quantity: 21]
omit from the column headed “Claimed Price”:          6.44        substitute:             9.92
[31]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Mayne Pharma Doxycycline; Pricing Quantity/Pack Quantity: 21]
omit from the column headed “Claimed Price”:          4.20        substitute:             5.07
[32]         Schedule 1, entry for Doxycycline in the form Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Doryx]
omit from the column headed “Claimed Price”:          4.30        substitute:             5.00
[33]         Schedule 1, entry for Doxycycline in the form Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Mayne Pharma Doxycycline]
omit from the column headed “Claimed Price”:          2.70        substitute:             3.59
[34]         Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg
omit from the column headed “Claimed Price”:          7.03        substitute:             8.06
[35]         Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg
omit from the column headed “Claimed Price”:          8.04        substitute:             9.10
 
[36]         Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
omit from the column headed “Claimed Price”:          6.86        substitute:             8.95
[37]         Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
omit from the column headed “Claimed Price”:          7.43        substitute:             9.80
[38]         Schedule 1, after entry for Escitalopram in the form Tablet 20 mg (as oxalate)
insert:
Exemestane
Tablet 25 mg
Oral
Aromasin
30
84.64
86.50
[39]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 50 mg
omit from the column headed “Claimed Price”:          8.48        substitute:             9.23
[40]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 100 mg
omit from the column headed “Claimed Price”:          11.56     substitute:             12.30
[41]         Schedule 1, entry for Glipizide
omit from the column headed “Claimed Price”:          9.99        substitute:             13.33
[42]         Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Brand: Imdur Durule]
omit from the column headed “Claimed Price”:          5.68        substitute:             6.35
[43]         Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Brand: Monodur 60 mg]
omit from the column headed “Claimed Price”:          5.02        substitute:             5.52
[44]         Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 120 mg (sustained release)
omit from the column headed “Claimed Price”:          10.06     substitute:             10.74
[45]         Schedule 1, entry for Labetalol in the form Tablet containing labetalol hydrochloride 100 mg
(a)   omit from the column headed “Determined Price”:             7.16        substitute:             9.61
(b)   omit from the column headed “Claimed Price”:                  9.70        substitute:             12.52
[46]         Schedule 1, entry for Labetalol in the form Tablet containing labetalol hydrochloride 200 mg
(a)   omit from the column headed “Determined Price”:             11.79     substitute:             14.25
(b)   omit from the column headed “Claimed Price”:                  14.33     substitute:             17.17
[47]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg
omit from the column headed “Claimed Price”:          4.88        substitute:             5.73
 
[48]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg
omit from the column headed “Claimed Price”:          6.52        substitute:             7.38
[49]         Schedule 1, entry for Lisinopril in the form Tablet 5 mg
omit from the column headed “Claimed Price”:          4.90        substitute:             5.68
[50]         Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Brand: Zestril]
omit from the column headed “Claimed Price”:          6.19        substitute:             6.97
[51]         Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Brand: Zestril]
omit from the column headed “Claimed Price”:          7.22        substitute:             8.02
[52]         Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 5 mg
omit from the column headed “Claimed Price”:          9.53        substitute:             12.64
[53]         Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 10 mg [Pricing Quantity/Pack Quantity: 30]
omit from the column headed “Claimed Price”:          8.38        substitute:             11.59
[54]         Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 10 mg [Pricing Quantity/Pack Quantity: 100]
omit from the column headed “Claimed Price”:          23.34     substitute:             26.51
[55]         Schedule 1, entry for Meloxicam in the form Capsule 7.5 mg
omit from the column headed “Claimed Price”:          5.34        substitute:             5.98
[56]         Schedule 1, entry for Meloxicam in the form Capsule 15 mg
omit from the column headed “Claimed Price”:          7.01        substitute:             7.65
[57]         Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg
omit from the column headed “Claimed Price”:          5.34        substitute:             5.98
[58]         Schedule 1, entry for Meloxicam in the form Tablet 15 mg
omit from the column headed “Claimed Price”:          7.01        substitute:             7.65
[59]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg
omit from the column headed “Claimed Price”:          4.83        substitute:             5.44
[60]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg
omit from the column headed “Claimed Price”:          6.51        substitute:             7.12
[61]         Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 850 mg [Brand: Diabex 850]
omit from the column headed “Claimed Price”:          4.83        substitute:             5.44
[62]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 1 g
omit from the column headed “Claimed Price”:          6.89        substitute:             7.51
[63]         Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 1 g
omit from the column headed “Claimed Price”:          6.51        substitute:             7.12
[64]         Schedule 1, entry for Methylprednisolone
omit from the column headed “Claimed Price”:          11.11     substitute:             12.57
[65]         Schedule 1, entry for Mirtazapine in the form Tablet 15 mg (orally disintegrating)
omit from the column headed “Claimed Price”:          6.32        substitute:             6.60
[66]         Schedule 1, entry for Mirtazapine in the form Tablet 30 mg
omit from the column headed “Claimed Price”:          7.20        substitute:             8.04
[67]         Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)
omit from the column headed “Claimed Price”:          8.14        substitute:             8.44
[68]         Schedule 1, entry for Mirtazapine in the form Tablet 45 mg
omit from the column headed “Claimed Price”:          10.38     substitute:             11.22
[69]         Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)
omit from the column headed “Claimed Price”:          11.86     substitute:             12.15
[70]         Schedule 1, entry for Naproxen in the form Tablet 250 mg
(a)   omit from the column headed “Determined Price”:             2.80        substitute:             3.38
(b)   omit from the column headed “Claimed Price”:                  3.70        substitute:             4.42
[71]         Schedule 1, entry for Nitrazepam
(a)   omit from the column headed “Determined Price”:             1.28        substitute:             1.50
(b)   omit from the column headed “Claimed Price”:                  2.20        substitute:             2.65
[72]         Schedule 1, entry for Omeprazole
omit from the column headed “Claimed Price”:          7.48        substitute:             8.32
[73]         Schedule 1, entry for Perindopril [Brands: Coversyl 2.5mg; and PREXUM 2.5]
omit from the column headed “Claimed Price”:          3.67        substitute:             4.15
[74]         Schedule 1, entry for Piroxicam in the form Capsule 10 mg
omit from the column headed “Claimed Price”:          7.16        substitute:             10.33
[75]         Schedule 1, entry for Piroxicam in the form Capsule 20 mg
omit from the column headed “Claimed Price”:          6.76        substitute:             9.90
[76]         Schedule 1, entry for Piroxicam in the form Dispersible tablet 20 mg
omit from the column headed “Claimed Price”:          7.57        substitute:             10.83
[77]         Schedule 1, entry for Prochlorperazine
omit from the column headed “Claimed Price”:          3.34        substitute:             3.94
[78]         Schedule 1, entry for Propranolol in the form Tablet containing propranolol hydrochloride 10 mg
(a)   omit from the column headed “Determined Price”:             3.05        substitute:             2.56
(b)   omit from the column headed “Claimed Price”:                  6.08        substitute:             5.11
[79]         Schedule 1, entry for Propranolol in the form Tablet containing propranolol hydrochloride 40 mg
(a)   omit from the column headed “Determined Price”:             3.35        substitute:             2.81
(b)   omit from the column headed “Claimed Price”:                  6.38        substitute:             5.36
[80]         Schedule 1, entry for Quinapril in the form Tablet 5 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          3.96        substitute:             5.79
[81]         Schedule 1, entry for Quinapril in the form Tablet 10 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          5.21        substitute:             7.05
[82]         Schedule 1, entry for Quinapril in the form Tablet 20 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          6.19        substitute:             8.03
[83]         Schedule 1, entry for Ranitidine in each of the forms: Tablet 150 mg (as hydrochloride); and Tablet 300 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          5.26        substitute:             5.47
[84]         Schedule 1, entry for Sertraline in each of the forms: Tablet 50 mg (as hydrochloride); and Tablet 100 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          2.73        substitute:             6.27
[85]         Schedule 1, entry for Spironolactone in the form Tablet 25 mg
omit from the column headed “Claimed Price”:          6.76        substitute:             9.87
[86]         Schedule 1, entry for Spironolactone in the form Tablet 100 mg
omit from the column headed “Claimed Price”:          20.92     substitute:             24.10
[87]         Schedule 1, entry for Sulfasalazine
omit from the column headed “Claimed Price”:          21.27     substitute:             21.77
[88]         Schedule 1, entry for Tamoxifen
omit from the column headed “Claimed Price”:          11.29     substitute:             11.55
[89]         Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg
omit from the column headed “Claimed Price”:          2.59        substitute:             3.18
[90]         Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg
omit from the column headed “Claimed Price”:          5.63        substitute:             6.71
[91]         Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg
omit from the column headed “Claimed Price”:          7.11        substitute:             8.40
[92]         Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg
omit from the column headed “Claimed Price”:          8.34        substitute:             9.79
[93]         Schedule 1, entry for Trandolapril in the form Capsule 500 micrograms
omit from the column headed “Claimed Price”:          3.90        substitute:             4.64
[94]         Schedule 1, entry for Trandolapril in the form Capsule 1 mg
omit from the column headed “Claimed Price”:          6.19        substitute:             6.95
[95]         Schedule 1, entry for Trandolapril in the form Capsule 2 mg
omit from the column headed “Claimed Price”:          6.96        substitute:             7.70
[96]         Schedule 1, entry for Trandolapril in the form Capsule 4 mg
omit from the column headed “Claimed Price”:          10.87     substitute:             11.61
[97]         Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg
omit from the column headed “Claimed Price”:          7.09        substitute:             7.33
[98]         Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg
omit from the column headed “Claimed Price”:          13.46     substitute:             13.60